Literature DB >> 8075646

Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease.

C M van Duijn1, P de Knijff, M Cruts, A Wehnert, L M Havekes, A Hofman, C Van Broeckhoven.   

Abstract

Several studies have reported an association of the apolipoprotein E allele epsilon 4 (APOE*4) to familial and sporadic late-onset Alzheimer's disease (LOAD). Here we report on the relationship between APOE*4 and early-onset Alzheimer's disease (EOAD) in a Dutch population-based study. The frequency of the APOE*4 allele was 2.3 times higher among EOAD cases compared to controls. Among patients, the allele frequency was 1.6 times higher in those with a positive family history than in those without. A significant increase in risk of EOAD was found for subjects homozygous for APOE*4 regardless of family history of dementia, but an increase in EOAD risk for APOE*4 heterozygotes could only be shown in subjects with a positive family history. Our study demonstrates a significant association between APOE*4 and EOAD which is modified by family history of dementia.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8075646     DOI: 10.1038/ng0594-74

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  85 in total

1.  Risk of dementia in parents of probands with and without the apolipoprotein E4 allele. The EVA study.

Authors:  S Danet; T Brousseau; F Richard; P Amouyel; C Berr
Journal:  J Epidemiol Community Health       Date:  1999-07       Impact factor: 3.710

Review 2.  Why should primary care physicians know about the genetics of dementia?

Authors:  L E Pinsky; W Burke; T D Bird
Journal:  West J Med       Date:  2001-12

3.  Association of Early-Onset Alzheimer Disease With Elevated Low-Density Lipoprotein Cholesterol Levels and Rare Genetic Coding Variants of APOB.

Authors:  Thomas S Wingo; David J Cutler; Aliza P Wingo; Ngoc-Anh Le; Gil D Rabinovici; Bruce L Miller; James J Lah; Allan I Levey
Journal:  JAMA Neurol       Date:  2019-07-01       Impact factor: 18.302

4.  Genetic analysis of BDNF and TrkB gene polymorphisms in Alzheimer's disease.

Authors:  Saila Vepsäläinen; Eero Castren; Seppo Helisalmi; Susan Iivonen; Arto Mannermaa; Maarit Lehtovirta; Tuomo Hänninen; Hilkka Soininen; Mikko Hiltunen
Journal:  J Neurol       Date:  2005-02-23       Impact factor: 4.849

5.  Autosomal recessive causes likely in early-onset Alzheimer disease.

Authors:  Thomas S Wingo; James J Lah; Allan I Levey; David J Cutler
Journal:  Arch Neurol       Date:  2011-09-12

Review 6.  Epidemiology of the dementias: recent developments and new approaches.

Authors:  C M van Duijn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-05       Impact factor: 10.154

7.  C9ORF72 repeat expansions and other FTD gene mutations in a clinical AD patient series from Mayo Clinic.

Authors:  Aleksandra Wojtas; Kristin A Heggeli; Nicole Finch; Matt Baker; Mariely Dejesus-Hernandez; Steven G Younkin; Dennis W Dickson; Neill R Graff-Radford; Rosa Rademakers
Journal:  Am J Neurodegener Dis       Date:  2012-05-16

8.  Apolipoprotein E epsilon 4 allele is a risk factor for familial and sporadic presenile Alzheimer's disease in both homozygote and heterozygote carriers.

Authors:  D St Clair; M Rennie; E Slorach; J Norrman; C Yates; A Carothers
Journal:  J Med Genet       Date:  1995-08       Impact factor: 6.318

9.  Chromogranin B P413L variant as risk factor and modifier of disease onset for amyotrophic lateral sclerosis.

Authors:  Francois Gros-Louis; Peter M Andersen; Nicolas Dupre; Makoto Urushitani; Patrick Dion; Frederique Souchon; Monique D'Amour; William Camu; Vincent Meininger; Jean-Pierre Bouchard; Guy A Rouleau; Jean-Pierre Julien
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-09       Impact factor: 11.205

10.  Genetic Determinants of Survival in Patientswith Alzheimer’s Disease.

Authors:  Xingbin Wang; Oscar Lopez; Robert A Sweet; James T Becker; Steven T DeKosky; Mahmud M Barmada; Eleanor Feingold; F Yesim Demirci; M Ilyas Kamboh
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.